Combretastatin A4
SIGMA/C7744 - ≥98% (HPLC), powder
Synonym: 1-
CAS Number: 117048-59-6
Empirical Formula (Hill Notation): C18H20O5
Molecular Weight: 316.35
MDL Number: MFCD03453309
Linear Formula: C18H20O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| form | powder |
| InChI | 1S/C18H20O5/c1-20-15-8-7- |
| InChI key | HVXBOLULGPECHP-WAYWQWQTSA |
| Quality Level | 100 ![]() |
| SMILES string | COc1ccc(C=C/c2cc(OC)c(OC |
| solubility | DMSO: >10 mg/mL |
| storage temp. | −20°C |
| Application: | Combretastatin A4 has been used: • as an anti-tubulin agent to determine the effects of isocitrate dehydrogenases (IDH1 and IDH2) proteins in G2/M phase • to evaluate the anti-proliferative and pro-apoptotic properties of biphenyl CA4 derivatives in both 2D and 3D cancerous and non-cancerous cell models • as a microtubule inhibitor to study its effects on motility of Ascaris suum L3 larvae |
| Biochem/physiol Actions: | Combretastatin A4 is a potent microtubule targeting agent (MTA). |
| Biochem/physiol Actions: | Combretastatin A4 is a vascular disrupting agent (VDA) that targets tumor vasculature to inhibit angiogenesis. |
| Biochem/physiol Actions: | Combretastatin A4 is a vascular disrupting agent (VDA) that targets tumor vasculature to inhibit angiogenesis. It inhibits tubulin polymerization at the colchicine-binding site of beta-tubulin. It has antitumor activity by inhibiting AKT function in human gastric cells. The inhibited AKT activation causes decreased cell proliferation, cell cycle arrest, and reduced in vitro migration/invasiveness and in vivo metastatic ability. Combretastatin A4 is a natural stilbenoid phenol. |
| General description: | Combretastatin A4 belong to the class of colchicinoids compounds. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS05,GHS06 |
| Signal word | Danger |
| Hazard statements | H301 + H311 + H331 - H318 |
| Precautionary statements | P261 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P311 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 23/24/25-41 |
| Safety Statements | 26-36/37-39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |



